Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Current Diabetes Reports

Issue 6/2006

Content (14 Articles)

Invited Commentary

An appraisal of aspirin therapy in diabetes

John A. Colwell

Web alert

Clinical Trials Report

Treatment of prediabetic neuropathy

Andrew J. M. Boulton

An update on autonomic neuropathy affecting the gastrointestinal tract

Liza K. Phillips, Christopher K. Rayner, Karen L. Jones, Michael Horowitz

Cardiovascular autonomic neuropathy: Diagnosis and management

Aaron I. Vinik, Tomris Erbas

Central nervous system involvement in diabetes mellitus

Dinesh Selvarajah, Solomon Tesfaye

The diabetic foot: The importance of biofilms and wound bed preparation

Stephen C. Davis, Lisa Martinez, Robert Kirsner

Negative pressure wound therapy: Evidence-based treatment for complex diabetic foot wounds

Jennifer J. Suess, Paul J. Kim, John S. Steinberg

Clinical Trials Report

Clinic versus home blood pressure measurements in patients with CKD

Robert Stanton

Lipids and diabetic nephropathy

Rey F. Rosario, Sharma Prabhakar

Inflammation and diabetic nephropathy

Carmen Mora, Juan F. Navarro

Anemia and diabetic nephropathy

Eberhard Ritz

Transplantation for type 1 diabetes: Whole organ pancreas and islet cells

Martha Pavlakis, Khalid Khwaja

Diabetic Nephropathy: Worldwide epidemic and effects of current treatment on natural history

Peter Rossing

Sep 06
Issue: 5/2006
Mar 07
Issue: 1/2007

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits